Press release
Masimo Files Investor Presentation Highlighting Innovation-Driven Value, Strategic Initiatives to Deliver Robust Growth and Margin Expansion and Risks of Ceding Control to Politan
Masimo’s Strategy Capitalizes on Innovation to Enhance Growth and Create Value for All Stockholders Politan is Making a Bid for Control Without Paying a
About this update from Masimo Corporation
[{"type":"text","content":"\nMasimo’s Strategy Capitalizes on Innovation to Enhance Growth and Create Value for All Stockholders\n\n\nPolitan is Making a Bid for Control Without Paying a Premium or Articulating a Clear Plan\n\n\nPolitan is Seeking to Replace Masimo Founder, Chairman and CEO Joe Kiani with Inferior Politan Nominees\n\n\nPolitan’s Actions are a Threat to Stockholder Value\n\n\nMasimo Has a Better Plan and Better Nominees\n\n\nStrongly Encourages Stockholders to Vote FOR Joe Kiani and Christopher Chavez on the GOLD Proxy Card\n\n\nVisit ProtectMasimosFuture.com for More Information\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) today filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its Annual Meeting of Stockholders to be held on July 25, 2024. The presentation lays out in detail:\n\n\n\nThe Company’s robust track record of innovation, led by Masimo Founder, Chairman and CEO Joe Kiani, that supports Masimo’s longstanding valuation premium to industry peers;\n\n\n\nMasimo’s strategic initiatives for sustained growth and margin expansion that are expected to more than double adjusted EPS to ~$8 by 2029; and\n\n\n\nThe Company’s belief that Politan’s value-destructive agenda to oust Mr. Kiani and take control of Masimo without paying a premium or articulating an exercisable plan poses a significant risk to the value of the Company.\n\n\n\nTo safeguard stockholders’ investments and ensure continued value creation, the Board strongly recommends that stockholders vote FOR Masimo’s highly qualified director nominees, Joe Kiani and Christopher Chavez.\n\n\nThe presentation is available here.\n\n\nAbout Masimo\n\n\nMasimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to improve life, improve patient outcomes, and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform othe...